| For: | Fu JF, Fang YL, Liang L, Wang CL, Hong F, Dong GP. A rabbit model of pediatric nonalcoholic steatohepatitis: The role of adiponectin. World J Gastroenterol 2009; 15(8): 912-918 [PMID: 19248189 DOI: 10.3748/wjg.15.912] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i8/912.htm |
| Number | Citing Articles |
| 1 |
Linqiang Zhang, Yongqiong Shi, Bin Liang, Xi Li. An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000434
|
| 2 |
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon, Ja Jun Jang, Joon Koo Han, Byung Ihn Choi. Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging—An Experimental Study in a Rabbit Model. Radiology 2014; 270(1) doi: 10.1148/radiol.13122506
|
| 3 |
Beicheng Sun, Michael Karin. Obesity, inflammation, and liver cancer. Journal of Hepatology 2012; 56(3) doi: 10.1016/j.jhep.2011.09.020
|
| 4 |
Jack Leslie, Kishore A. Krishnamurthy, Indresh K. Gopalsamy, Patricia Inacio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca. Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models. Nature Reviews Gastroenterology & Hepatology 2026; 23(4) doi: 10.1038/s41575-025-01162-9
|
| 5 |
Bo Yun Hur, Jeong Min Lee, Woo Hyunsik, Kyung Bun Lee, Ijin Joo, Joon Koo Han, Byung Ihn Choi. Quantification of the Fat Fraction in the Liver Using Dual-Energy Computed Tomography and Multimaterial Decomposition. Journal of Computer Assisted Tomography 2014; 38(6) doi: 10.1097/RCT.0000000000000142
|
| 6 |
Yasutaka Baba, Sadao Hayashi, Kohei Nagasato, Michiyo Higashi, Nanako Tosuji, Shunro Sonoda, Takashi Yoshiura. Oxidative stress induced by portal vein embolization in fatty liver: Experimental study of a nonalcoholic steatohepatitis model. Biomedical Reports 2018; doi: 10.3892/br.2018.1141
|
| 7 |
|
| 8 |
Tomohiro Ogawa, Hideki Fujii, Katsutoshi Yoshizato, Norifumi Kawada. A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits. The American Journal of Pathology 2010; 177(1) doi: 10.2353/ajpath.2010.090895
|
| 9 |
Sheila Cristina L. Sanches, Leandra Naira Z. Ramalho, Marlei Josiele Augusto, Deisy Mara da Silva, Fernando Silva Ramalho. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. BioMed Research International 2015; 2015 doi: 10.1155/2015/574832
|
| 10 |
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li, Lin Wang. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020; 330 doi: 10.1016/j.cbi.2020.109199
|
| 11 |
Veronica Marin, Natalia Rosso, Matteo Dal Ben, Alan Raseni, Manuela Boschelle, Cristina Degrassi, Ivana Nemeckova, Petr Nachtigal, Claudio Avellini, Claudio Tiribelli, Silvia Gazzin, Anna Alisi. An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0158817
|
| 12 |
Kamilla Pedersen, Ankita Poojari, Simone Frederikke Colberg, Stine Marguerite Mechernsee, Jo Frøkjær Iversen, Romain Barrès, Jens Lykkesfeldt, Pernille Tveden-Nyborg. A Guinea Pig Model of Pediatric Metabolic Dysfunction-Associated Steatohepatitis: Poor Vitamin C Status May Advance Disease. Nutrients 2025; 17(2) doi: 10.3390/nu17020291
|
| 13 |
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(1) doi: 10.1016/j.jcmgh.2021.01.019
|
| 14 |
Amalia E. Yanni, George Agrogiannis, Tzortzis Nomikos, Elisabeth Fragopoulou, Alkisti Pantopoulou, Smaragdi Antonopoulou, Despoina Perrea. Oral supplementation with l-aspartate and l-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit. Amino Acids 2010; 38(5) doi: 10.1007/s00726-009-0340-x
|
| 15 |
K Widhalm, E Ghods. Nonalcoholic fatty liver disease: a challenge for pediatricians. International Journal of Obesity 2010; 34(10) doi: 10.1038/ijo.2010.185
|
| 16 |
Mikhaïl Van Herck, Luisa Vonghia, Sven Francque. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide. Nutrients 2017; 9(10) doi: 10.3390/nu9101072
|
| 17 |
Tung Thanh Tran, Phong Xuan Pham, Hien Thu Thi Dang, Quang Vinh Trinh, Duong Thuy Dau, Van Anh Thi Pham. Anti-atherosclerotic effects of combined Bambusa bambos (L.) Voss and Ananas comosus (L.) Merr. extract on hypercholesterolemic rabbits. Phytomedicine Plus 2025; 5(4) doi: 10.1016/j.phyplu.2025.100890
|
| 18 |
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon, Ja Jun Jang, Joon Koo Han, Byung Ihn Choi. Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging—An Experimental Study in a Rabbit Model. Radiology 2014; 270(1) doi: 10.1148/radiol.13122506
|
| 19 |
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232314762
|
| 20 |
Xia Wang, Sheng Zhang, Zhe Huang, Gang Tian, Xiaofan Liu, Lijun Chen, Liang An, Xumiao Li, Ningna Liu, Yang Ji, Yuedong Han. Influence of Gadoxetate disodium to the hepatic proton density fat fraction quantified with the Dixon sequences in a rabbit model. Abdominal Radiology 2024; 49(10) doi: 10.1007/s00261-024-04320-w
|
| 21 |
Yan-Lan Fang, Hong Chen, Chun-Lin Wang, Li Liang. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”. World Journal of Gastroenterology 2018; 24(27): 2974-2983 doi: 10.3748/wjg.v24.i27.2974
|
| 22 |
Linqiang Zhang, Xiaoyun Wu, Shasha Liao, Yunhai Li, Zhiguo Zhang, Qing Chang, Ruyue Xiao, Bin Liang. Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease. Biology Open 2016; 5(10) doi: 10.1242/bio.020875
|
| 23 |
M A Hyatt, D S Gardner, S Sebert, V Wilson, N Davidson, Y Nigmatullina, L L Y Chan, H Budge, M E Symonds. Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring. Reproduction 2011; 141(1) doi: 10.1530/REP-10-0325
|
| 24 |
Mário Cláudio Soares Sturzeneker, Sergio Ossamu Ioshii, Liz Andréa Villela Baroncini, Dalton Bertolim Précoma. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia. Atherosclerosis 2011; 216(1) doi: 10.1016/j.atherosclerosis.2011.01.047
|
| 25 |
Ahmed Abu Shanab, Paul Scully, Orla Crosbie, Martin Buckley, Liam O’Mahony, Fergus Shanahan, Sanaa Gazareen, Eileen Murphy, Eamonn M. M. Quigley. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8. Digestive Diseases and Sciences 2011; 56(5) doi: 10.1007/s10620-010-1447-3
|
| 26 |
Louise Wutsdorff, Julienne Mougnekabol, Peter Tang, Anja Reutzel-Selke, Igor M. Sauer, Nils Haep. Unveiling the Multifaceted Role of CIDEB: From Apoptosis to Lipid Metabolism and Liver Health. Livers 2024; 4(3) doi: 10.3390/livers4030030
|